テキサスにおける消化器がんの臨床試験
テキサス内の拠点で、消化器がんに関する26件の研究が参加者を募集しています。
テキサス内の都市
公式研究テキスト（英語）
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
被験者募集中第2相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06760819Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Texas Oncology - West Texas, Abilene
- Texas Oncology - West Texas, Amarillo
- Texas Oncology - Gulf Coast, Beaumont
- 他27件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07218926Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- MD Anderson, Houston
- NEXT Dallas, Irving
- NEXT Oncology San Antonio, San Antonio
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06128551Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
- Baylor College of Medicine, Houston
- The University of Texas MD Anderson Cancer Center, Houston
- NEXT Oncology Dallas, Irving
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/22更新 · NCT06445062Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) Cancers
- START San Antonio, San Antonio
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT07539311Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- START San Antonio, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/27更新 · NCT06582017A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- The University of Texas, MD Anderson Cancer Center, Houston
- UT Health Mays Cancer Center, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/11更新 · NCT05592626A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- GSK Investigational Site, Houston
- GSK Investigational Site, San Antonio
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/03更新 · NCT06885034Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/07/21更新 · NCT04629677Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
- MD Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/07/14更新 · NCT06420206A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
- NEXT Dallas, Dallas
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/07更新 · NCT07337525Telephone Support in Advanced Gastrointestinal Cancer
- MD Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/07/06更新 · NCT06532877Improving Comprehensive Care of Cancer Patients
- Baylor College of Medicine, Houston
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/30更新 · NCT05323409BOLSTER: Learning New Skills to Thrive
- The University of Texas MD Anderson Cancer Center, Houston
被験者募集中
18歳以上 · 全性別 · 2026/06/18更新 · NCT06936878Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
18歳以上 · 全性別 · 2026/06/12更新 · NCT00991094Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
- Clemments University Hospital, Dallas
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/05更新 · NCT07039526Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
- Sarah Cannon Research Institute at Mary Crowley, Dallas
- University of Texas, MD Anderson Cancer Center, Houston
- START, San Antonio
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT06040541A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- UT Southwestern Medical Center, Dallas
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/05/27更新 · NCT03093116Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- University of Texas at Austin, Austin
- Mary Crowley Cancer Research, Dallas
- The University of Texas MD Anderson Cancer Center, Houston
- 他1件
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/05/15更新 · NCT05379985A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- MD Anderson Cancer Center, Houston
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/04/22更新 · NCT07020221Molecular Epidemiology of Biliary Tree Cancers
- M D Anderson Cancer Center, Houston
被験者募集中観察研究
全年齢 · 全性別 · 2026/04/17更新 · NCT05179486Novel Rigidizing Overtube in Colonic Endoscopic Submucosal Dissection
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
被験者募集中
22歳以上 · 全性別 · 2026/03/24更新 · NCT06134687Traction vs. No Traction in Colonic ESD
- Baylor College of Medicine, Houston
- Baylor St. Lukes Medical Center (BSLMC), Houston
被験者募集中
18歳以上 · 全性別 · 2026/03/24更新 · NCT06159634Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
- UT Southwestern, Dallas
被験者募集中観察研究
全年齢 · 全性別 · 2025/08/15更新 · NCT05406167ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。